[Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
M. H. Beck, Carlos Roberto Berger, N Filipp, U Hundertmark, R Loewel
Abstract
M. H. Beck, Carlos Roberto Berger, N Filipp, U Hundertmark, R Loewel
Abstract
90 patients suffering from chronic skin diseases-mainly psoriasis vulgaris-were treated in a double-blind-study for two weeks with topical Clobetasol-17-propionate compared with other topical corticoids. In 81% was seen a better therapeutical effect on the Clobetasol-17-propionate treated skin area.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
90 patients suffering from chronic skin diseases-mainly psoriasis vulgaris-were treated in a double-blind-study for two weeks with topical Clobetasol-17-propionate compared with other topical corticoids. In 81% was seen a better therapeutical effect on the Clobetasol-17-propionate treated skin area.
Key concepts: Clobetasol propionate, Psoriasis, Dermatology, Medicine, Double blind, Alternative medicine, Pathology, Placebo